Plandai Biotech
Plandaí Biotechnology, Inc. does not have significant operations. Previously, it was involved in a biotechnology-related business. Plandaí Biotechnology, Inc. is based in Taipei, Taiwan.
Plandai Biotech (PLPL) - Total Assets
Latest total assets as of September 2024: $100.00K USD
Based on the latest financial reports, Plandai Biotech (PLPL) holds total assets worth $100.00K USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Plandai Biotech - Total Assets Trend (2003–2024)
This chart illustrates how Plandai Biotech’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Plandai Biotech - Asset Composition Analysis
Current Asset Composition (June 2024)
Plandai Biotech's total assets of $100.00K consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Plandai Biotech's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Plandai Biotech's current assets represent 0.0% of total assets in 2024, a decrease from 78.8% in 2003.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, up from -0.1% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Plandai Biotech Competitors by Total Assets
Key competitors of Plandai Biotech based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shaanxi Jinye Science Technology and Education Group Co Ltd
SHE:000812
|
China | CN¥5.75 Billion |
|
Tungkong Inc
SHE:002117
|
China | CN¥1.92 Billion |
|
Eternal Asia Supply Chain Management Ltd
SHE:002183
|
China | CN¥54.04 Billion |
|
Hongbo Co Ltd
SHE:002229
|
China | CN¥2.43 Billion |
|
Beijing Shengtong Printing Co Ltd
SHE:002599
|
China | CN¥2.14 Billion |
|
Shanghai Nar Industrial Co Ltd
SHE:002825
|
China | CN¥2.78 Billion |
|
Xuchang Ketop Testing Research Ins
SHE:003008
|
China | CN¥1.10 Billion |
|
GFM Services Bhd
KLSE:0039
|
Malaysia | RM644.83 Million |
Plandai Biotech - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Plandai Biotech generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Plandai Biotech is currently not profitable relative to its asset base.
Plandai Biotech - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.03 | 5.98 |
| Quick Ratio | 0.00 | 0.03 | 5.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-975.37K | $ -22.00 Million | $ 1.44 Million |
Plandai Biotech - Advanced Valuation Insights
This section examines the relationship between Plandai Biotech's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $100.00K |
| Market Capitalization | $17.95K USD |
Valuation Analysis
Below Book Valuation: The market values Plandai Biotech's assets below their book value (0.18 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Plandai Biotech's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Plandai Biotech (2003–2024)
The table below shows the annual total assets of Plandai Biotech from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | $100.00K | -- |
| 2023-06-30 | $0.00 | -- |
| 2022-06-30 | $0.00 | -- |
| 2021-06-30 | $7.26 Million | 0.00% |
| 2020-06-30 | $7.26 Million | +6.48% |
| 2017-06-30 | $6.82 Million | +5.72% |
| 2016-06-30 | $6.45 Million | -24.16% |
| 2015-06-30 | $8.50 Million | -12.17% |
| 2014-06-30 | $9.68 Million | +9.60% |
| 2013-06-30 | $8.84 Million | +45.87% |
| 2012-06-30 | $6.06 Million | +542.72% |
| 2011-06-30 | $942.41K | -45.46% |
| 2010-06-30 | $1.73 Million | +96.82% |
| 2009-06-30 | $877.89K | -25.20% |
| 2008-06-30 | $1.17 Million | -55.17% |
| 2007-06-30 | $2.62 Million | +14.26% |
| 2006-06-30 | $2.29 Million | +24.92% |
| 2005-06-30 | $1.83 Million | +7.64% |
| 2004-06-30 | $1.70 Million | 0.00% |
| 2003-06-30 | $1.70 Million | -- |